The MarketWatch News Department was not involved in the creation of this content. First-in-class isogenic model of the human neurovascular unit offers unparalleled human relevance for studying ...
Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration's (FDA) newly announced plan to reduce reliance on animal testing in ...
Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System, a self-contained instrument that cultures, incubates, and images up ...
Emulate, Inc., the leading provider of next-generation Organ-on-a-Chip technology, in partnership with FUJIFILM Cellular Dynamics, Inc., a pioneering global developer and manufacturer of human induced ...
First-in-class isogenic model of the human neurovascular unit offers unparalleled human relevance for studying blood-brain barrier drug transport and neuroinflammation. Emulate, Inc., the leading ...
The last few weeks have been busy for Jim Corbett. Corbett, the CEO of organ-chip developer Emulate, has been fielding requests from potential clients, as well as from early investors who say they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback